Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00JWA
|
||||
Former ID |
DNC010621
|
||||
Drug Name |
N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530694] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H13N3O2
|
||||
Canonical SMILES |
CC(=O)NC1=NC(=C(C=C1)C2=CC=NC=C2)C3=CC=CO3
|
||||
InChI |
1S/C16H13N3O2/c1-11(20)18-15-5-4-13(12-6-8-17-9-7-12)16(19-15)14-3-2-10-21-14/h2-10H,1H3,(H,18,19,20)
|
||||
InChIKey |
STFZQXRQDWXSGW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A1 receptor | Target Info | Inhibitor | [530694] | |
Adenosine A2b receptor | Target Info | Inhibitor | [530694] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [530694] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [530694] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.